ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
1.960
+0.040 (2.08%)
At close: May 6, 2026, 4:00 PM EDT
1.940
-0.020 (-1.02%)
After-hours: May 6, 2026, 7:37 PM EDT
ProKidney Revenue
In the year 2025, ProKidney had annual revenue of $893.00K with 1,075.00% growth. ProKidney had revenue of $225.00K in the quarter ending December 31, 2025, with 196.05% growth.
Revenue (ttm)
$893.00K
Revenue Growth
+1,075.00%
P/S Ratio
662.76
Revenue / Employee
$3,866
Employees
231
Market Cap
591.84M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 893.00K | 817.00K | 1,075.00% |
| Dec 31, 2024 | 76.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ginkgo Bioworks Holdings | 170.16M |
| Entrada Therapeutics | 25.42M |
| Crescent Biopharma | 11.88M |
| Prothena Corporation | 9.68M |
| Prime Medicine | 4.63M |
| Avalo Therapeutics | 59.00K |
| Altimmune | 41.00K |
PROK News
- 6 weeks ago - ProKidney Expands Senior Leadership Team with Appointment of Greg Madison as Chief Commercial Officer - GlobeNewsWire
- 4 months ago - ProKidney Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts
- 4 months ago - ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 months ago - ProKidney Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference - Transcripts
- 6 months ago - ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates - GlobeNewsWire
- 6 months ago - ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025 - GlobeNewsWire
- 6 months ago - ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference - GlobeNewsWire
- 7 months ago - ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2025 - GlobeNewsWire